Our EMR-integrated cognition product is available. Read more about Cognition Chronicle here.
We've updated our End User License Agreement as of October 1, 2021. You can view the updated policy here.
Self-guided by patient
Used in over 1 million assessments worldwide
Successfully integrated into all major EMRs
Our vision is to enable transformational improvement in patient care by providing medical devices for collecting highly standardized clinical data and patient-reported outcomes, in any medical or home setting.
Qr8 Health’s platform technology incorporates standardized, validated digital tests for the measurement of neurological and motor function along with patient reported outcomes that are self-guided on a mobile tablet device and easily integrated into electronic health records.
Our platform technology is used in the detection and treatment of:
Information processing speed and memory are often negatively affected in many neurological disorders and are important to identify early. Cognition Chronicle™ is an FDA registered digital application that quickly evaluates processing speed, spatial & verbal memory for use in all patient groups. Cognition Chronicle enables the ability to easily see how test results are trending over time.
Information processing speed and memory are often negatively affected in many neurological disorders and are important to identify early. Cognition Snapshot™ is an FDA registered digital application that quickly evaluates processing speed, spatial & verbal memory for use in all patient groups. Cognition Chronicle enables the ability to quickly evaluate patients in a single visit.
Information processing speed can be impacted by neurological disorders such as Alzheimer’s disease and Parkinson’s disease. Identification is important as processing speed impairment can potentially be modified with cognitive training and future therapeutic intervention.
The first example of our platform in clinical use is the Multiple Sclerosis Performance Test (MSPT), an iPad-based assessment tool designed to objectively quantify major motor, visual, and cognitive symptoms for patients with multiple sclerosis. The MSPT is administered during routine clinical visits and test results are automatically posted to the patient’s electronic health record.
MSPT is current being utilized by the Cleveland Clinical Mellen Center for Multiple Sclerosis and in over 50 multiple sclerosis centers globally.
David Blum, Wendy Gabel & Jane Rhodes, PhD
Rao, S., Galioto, R., Sokolowski et al. Eur J Neurol 2020 Feb 3
Gabrielle Macaron, Brandon P. Moss, Hong Li et al. Neurol Clin Pract Sept 2019, 10.1212
Rao S., Losinski G., Mourany L., et al. | Mult Scier 2017 Dec;23(14):1929-1937